These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Design, synthesis, and biological evaluation of new pyrazoloquinazoline derivatives as dual COX-2/5-LOX inhibitors. Shaaban MA, Kamal AM, Faggal SI, Farag NA, Aborehab NM, Elsahar AE, Mohamed KO. Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000027. PubMed ID: 32696514 [Abstract] [Full Text] [Related]
8. Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition. Ghanim AM, Rezq S, Ibrahim TS, Romero DG, Kothayer H. Eur J Med Chem; 2021 Jul 05; 219():113457. PubMed ID: 33892270 [Abstract] [Full Text] [Related]
9. Novel 1-[4-(Aminosulfonyl)phenyl]-1H-1,2,4-triazole derivatives with remarkable selective COX-2 inhibition: design, synthesis, molecular docking, anti-inflammatory and ulcerogenicity studies. Abuo-Rahma Gel-D, Abdel-Aziz M, Farag NA, Kaoud TS. Eur J Med Chem; 2014 Aug 18; 83():398-408. PubMed ID: 24983538 [Abstract] [Full Text] [Related]
10. New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation. Ahmed EM, Hassan MSA, El-Malah AA, Kassab AE. Bioorg Chem; 2020 Jan 18; 95():103497. PubMed ID: 31838289 [Abstract] [Full Text] [Related]
11. Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents. Ahmed EM, Kassab AE, El-Malah AA, Hassan MSA. Eur J Med Chem; 2019 Jun 01; 171():25-37. PubMed ID: 30904755 [Abstract] [Full Text] [Related]
12. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids. Abdu-Allah HHM, Abdelmoez AAB, Tarazi H, El-Shorbagi AA, El-Awady R. Bioorg Chem; 2020 Jan 01; 94():103378. PubMed ID: 31677858 [Abstract] [Full Text] [Related]
13. Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors. Gedawy EM, Kassab AE, El Kerdawy AM. Eur J Med Chem; 2020 Mar 01; 189():112066. PubMed ID: 31982653 [Abstract] [Full Text] [Related]
14. New benzothiophene derivatives as dual COX-1/2 and 5-LOX inhibitors: synthesis, biological evaluation and docking study. El-Miligy MM, Hazzaa AA, El-Messmary H, Nassra RA, El-Hawash SA. Future Med Chem; 2017 Apr 01; 9(5):443-468. PubMed ID: 28362117 [Abstract] [Full Text] [Related]
16. Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: Synthesis, biological activities in vitro and docking study. Lamie PF, Ali WAM, Bazgier V, Rárová L. Eur J Med Chem; 2016 Nov 10; 123():803-813. PubMed ID: 27541263 [Abstract] [Full Text] [Related]
17. Pyrazole-hydrazone derivatives as anti-inflammatory agents: Design, synthesis, biological evaluation, COX-1,2/5-LOX inhibition and docking study. Abdelgawad MA, Labib MB, Abdel-Latif M. Bioorg Chem; 2017 Oct 10; 74():212-220. PubMed ID: 28865292 [Abstract] [Full Text] [Related]
18. Synthesis and biological evaluation of new nicotinate derivatives as potential anti-inflammatory agents targeting COX-2 enzyme. El-Dash Y, Khalil NA, Ahmed EM, Hassan MSA. Bioorg Chem; 2021 Feb 10; 107():104610. PubMed ID: 33454504 [Abstract] [Full Text] [Related]